Stryker's (SYK) OptaBlate Tumor Ablation System Gets FDA Nod

This article was originally published on Nasdaq

Although Stryker Corporation SYK received the FDA’s 510(k) clearance for its OptaBlate bone tumor ablation system on Tuesday, shares of the company continued their declining trend amid Fed rate hike. The company’s shares have been down 3.6% since Sep 20, following the reg

Responses